|
Field
Trial Start Date
|
Before
July 01, 2017
|
After
September 28, 2017
|
|
Field
Trial End Date
|
Before
June 30, 2018
|
After
April 30, 2018
|
|
Field
Last Published
|
Before
June 06, 2017 03:37 PM
|
After
September 28, 2017 09:13 AM
|
|
Field
Intervention Start Date
|
Before
July 01, 2017
|
After
September 28, 2017
|
|
Field
Intervention End Date
|
Before
June 30, 2018
|
After
April 30, 2018
|
|
Field
Primary Outcomes (Explanation)
|
Before
We will construct measures for the following FP-related outcomes: use of oral contraceptives, use of injectables, use of other short-acting method, and use of long-active reversible method. For ANC-related outcomes, we will measure any ANC visit, gestational age at first ANC visit, and number of ANC visits. Willingness to pay is computed by Becker-DeGroot-Marschak (BDM) or/and Take it or leave it (TIOLI) method
|
After
We will construct measures for the following FP-related outcomes: use of oral contraceptives, use of injectables, use of other short-acting method, and use of long-active reversible method. For ANC-related outcomes, we will measure any ANC visit, gestational age at first ANC visit, and number of ANC visits. Demand for pregnancy test kit is computed by Becker-DeGroot-Marschak (BDM) or/and Take it or leave it (TIOLI) method.
|
|
Field
Experimental Design (Public)
|
Before
Following baseline data collection, half of the sample will be provided with a home pregnancy test to assess how resolving uncertainty about pregnancy status affects beliefs and behaviors.
|
After
Following baseline data collection, around half of the sample will be provided with a home pregnancy test to assess how resolving uncertainty about pregnancy status affects beliefs and behaviors.
|
|
Field
Sample size (or number of clusters) by treatment arms
|
Before
150 women, offer free pregnancy test at baseline and given a pregnancy test kit for future use
150 women, offer free pregnancy test at baseline
150 women, given a pregnancy test kit for future use
150 women, control group. No intervention.
|
After
180 women, offer free pregnancy test at baseline and at follow up survey.
180 women, offer free pregnancy test at baseline.
240 women, control group. No intervention.
|
|
Field
Power calculation: Minimum Detectable Effect Size for Main Outcomes
|
Before
According to the DHS 2011 in Uganda, 19.22% of people use modern contraceptive in South West region (sample weighted).
Following the power calculation of two proportion test (standard deviation automatically calculated by mean since the outcome is binary variable), the treatment group has to have 30.62% take up of family planning with power set at 0.9. This is the 11.41 percentage points increase from the baseline.
|
After
According to the DHS 2016 in Uganda, 34.1% of people use modern contraceptive in Ankole region (sample weighted).
Following the power calculation of two proportion test, the treatment group has to have 47.31% take up of family planning with power set at 0.9. This is the 13.21 percentage points increase from the baseline.
|
|
Field
Intervention (Hidden)
|
Before
Randomization A: Randomly provide half of the (non-pregnant) women a home pregnancy test to take at the time of the baseline survey to assess how resolving uncertainty about pregnancy status affects beliefs and behaviors;
Randomization B: Randomize ½ of the respondents (non-pregnant), stratified by Randomization A, to receive a free pregnancy tests to keep for themselves at the end of the baseline.
|
After
Randomization A: Randomly provide half of the (non-pregnant) women a home pregnancy test to take at the time of the baseline survey to assess how resolving uncertainty about pregnancy status affects beliefs and behaviors.
Randomization B: Randomize some of the respondents (non-pregnant) stratified by Randomization A, to receive a free pregnancy tests in the follow up survey.
|